PRNewsWire
16 Jul 2026, 23:52 UTC · 13w ago
Verdict
Headline takes no side. We score HCA −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
HCA Healthcare sharply lowered its full-year 2026 profit guidance.
More negative than 99% of claims this week
An unfavorable shift in HCA's payer mix reduced revenue by approximately $400 million in the second quarter of 2026.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 94% of claims this week
Pomerantz LLP is investigating HCA Healthcare for potential securities fraud or unlawful business practices following the guidance cut.
More negative than 84% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company lowered its profit guidance, saw a significant stock price drop, and is being investigated for potential securities fraud.
More negative than 85% of ticker scores this week
The company is the subject of a legal investigation by Pomerantz LLP on behalf of investors.
More negative than 85% of ticker scores this week
The company is the subject of a legal investigation by Pomerantz LLP on behalf of investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
2h ago
+19.1%
Price is moving against the score
$459.40 vs $385.74 close before publication (Jul 16) · not market-adjusted
HCA chart →
